Management of early and late complications of ileocolonic continent urinary reservoir (Miami pouch)

Gynecologic Oncology
M PenalverR Malik

Abstract

The object of this study is to review our experience and formulate a plan for early recognition and effective management of early and late complications seen in patients who have undergone construction of the ileocolonic continent urinary reservoir. Charts of patients who underwent continent urinary diversion at the Division of Gynecologic Oncology, University of Miami School of Medicine, from 1988 to 1996 were reviewed. We analyzed our data in terms of early and late (beyond 6 weeks) complications resulting directly from the operation or from this form of urinary diversion. Urinary diversion via the continent ileocolonic reservoir has been performed at our institution since February 1988. Sixty-six women have undergone construction of the Miami pouch over the past 81 years. Sixty-three of 66 patients needed a reservoir as a part of total pelvic exenteration for persistent or recurrent gynecologic malignancy. Three patients underwent reservoir construction for repair of vesicovaginal fistula. Sixty-two of 66 patients (95%) have a history of prior pelvic radiation. A total of 35 patients (53%) suffered early complications resulting in an operative mortality rate of 9% (6 of 66 patients). Early complications related to the constr...Continue Reading

References

Apr 1, 1979·American Journal of Surgery·J C Russell, J P Welch
Sep 1, 1993·Revista médica de Panamá·G Corcione, M Guerrero

❮ Previous
Next ❯

Citations

Nov 21, 2008·World Journal of Urology·Richard E HautmannBjoern G Volkmer
Sep 22, 2012·European Urology·Richard E HautmannUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
Apr 25, 2006·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·F Lopes de QueirozP Rosa da Silva
Mar 26, 2005·Gynecologic Oncology·Emery M SalomManuel A Penalver
Feb 22, 2002·Gynecologic Oncology·Robert L ColemanKenneth D Hatch
Jun 9, 2016·Expert Review of Anticancer Therapy·Valentina ZanfagninAndrea Mariani
Jun 19, 2016·Asian Journal of Surgery·Yu Guang TanMelissa C C Teo
Oct 3, 1999·Seminars in Surgical Oncology·D S ChiW J Hoskins
Nov 7, 2003·Cancer·Frederick B StehmanJ Taylor Wharton
Sep 9, 2004·Current Opinion in Obstetrics & Gynecology·Ramin MirhashemiTajnoos Yazdani
Feb 1, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dirk Michael Forner, Björn Lampe
Dec 24, 2003·The Cancer Journal·Emery M Salom, Manuel A Penalver
Dec 25, 2003·Critical Reviews in Oncology/hematology·Roberto AngioliManuel Penalver
May 1, 2004·American Journal of Obstetrics and Gynecology·Emery M SalomManuel Peñalver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.